# Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation

> **NCT04457232** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Metastatic Malignant Neoplasm in the Prostate Gland
- Prostate Carcinoma
- Recurrent Prostate Carcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Gallium Ga 68 FAPi-46
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT04457232
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-09
- **Primary completion:** 2023-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457232, "Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04457232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*